Efficacy and safety of subcutaneous anifrolumab administration compared to intravenous formulation
⚠ No ClinicalTrials.gov registry ID found for this program. This trial was announced but no registered study has been identified. CelluTarget flags this distinction rather than treating announced and registered trials as equivalent.